Article
Gastrin producing syngeneic mesenchymal stem cells protect non-obese diabetic mice from type 1 diabetes
2021-05-15
Abstract excerpt
Progressive destruction of pancreatic islet β-cells by immune cells is a primary feature of type 1 diabetes (T1D) and therapies that can restore the functional β-cell mass are needed to alleviate disease progression. Here, we report the use of mesenchymal stromal/stem cells (MSCs) for the production and delivery of Gastrin, a peptide-hormone which is produced by intestinal cells and fetal islets and can increase β...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 970f8559-03f7-50ae-8f5c-9f0ff0fc3da2
- DOI
- 10.1101/2021.05.13.444059
